xCures
Bryan Federowicz has a diverse work experience spanning multiple industries. Bryan began their career at Peter Millar as an Order Fulfillment Associate/Intern, where they were responsible for handling the entire order fulfillment process and working closely with the Special Events Supervisor on implementing clothing and gift packages for golf events. Afterward, they worked as a Diamond Account Specialist at Mizuno USA, and later joined Clinipace Worldwide. At Clinipace, they held various roles such as Clinical Trial Associate, Internal Clinical Research Associate, Study Start-Up Manager, Manager of Site Management, and Associate Director of Global Study Start-Up and Site Management Services. Bryan then worked as a Consultant at Pharma Initiatives before joining their current company, xCures, where they hold the position of Director of Clinical Operations.
Bryan Federowicz pursued their Bachelor of Science (B.S.) degree in Parks, Recreation and Tourism Management from North Carolina State University. Bryan attended the university from 2008 to 2013. During the same period, they also completed a Minor in Business Administration and Management, General from the same institution.
This person is not in any offices
xCures
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.